Found 6 matching trials
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies PHASE2 To reduce the number of donors treated with IV AMD3100 who require a second...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy PHASE3 Patients 60 to 70 years of age with newly diagnosed multiple myeloma were p...
Show More Location
Multiple Locations
Learn More & Join Trial
Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors PHASE1 This study will assess the feasibility of utilizing a reduced intensity con...
Show More Location
Kenneth DeSantes., MD
Learn More & Join Trial
Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation PHASE1 In this trial, the investigators will begin to explore the possibility that...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors NA This is a standard of care treatment guideline for high risk or relapsed so...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial